The commissioning of olanzapine long-acting (depot) injection is accepted in Devon for the treatment of patients with schizophrenia who are non-adherent to antipsychotic medication or first generation antipsychotic depot injections are not clinically appropriate.
| Filename: | Olanzapine long-acting (depot) injection for schizophrenia |
| Filetype: | |
| Filesize: | 95.04 KB |
| Date uploaded: | 12th November 2014 |
| Date updated: | 8th December 2022 |
